Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-15 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-13 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-13 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-11 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-11 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-10 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |